<VariationArchive VariationID="522878" VariationName="NM_003124.4(SPR):c.596del" VariationType="Deletion" Accession="VCV000522878" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2018-04-29" MostRecentSubmission="2022-12-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="513525" VariationID="522878">
      <GeneList>
        <Gene Symbol="SPR" FullName="sepiapterin reductase" GeneID="6697" HGNC_ID="HGNC:11257" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="72887408" stop="72892158" display_start="72887408" display_stop="72892158" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="73114511" stop="73119288" display_start="73114511" display_stop="73119288" Strand="+" />
          </Location>
          <OMIM>182125</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003124.4(SPR):c.596del</Name>
      <CanonicalSPDI>NC_000002.12:72891345:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="72891346" stop="72891346" display_start="72891346" display_stop="72891346" variantLength="1" positionVCF="72891345" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="73118475" stop="73118475" display_start="73118475" display_stop="73118475" variantLength="1" positionVCF="73118474" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.73118476del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.73118476del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.72891347del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.72891347del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008234.1" sequenceAccession="NG_008234" sequenceVersion="1" change="g.8965del">
            <Expression>NG_008234.1:g.8965del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658795814" DB="ClinGen" />
        <XRef Type="rs" ID="1553498582" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003124.4(SPR):c.596del AND Dopa-responsive dystonia due to sepiapterin reductase deficiency" Accession="RCV000626068" Version="12">
        <ClassifiedConditionList TraitSetID="3527">
          <ClassifiedCondition DB="MedGen" ID="C0268468">Dopa-responsive dystonia due to sepiapterin reductase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-12-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-12-18" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-04-29" MostRecentSubmission="2022-12-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3527" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1574" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Dopa-responsive dystonia due to sepiapterin reductase deficiency</ElementValue>
                <XRef ID="MONDO:0012994" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">DYT-SPR</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sepiapterin reductase deficiency</ElementValue>
                <XRef ID="Sepiapterin+reductase+deficiency/6509" DB="Genetic Alliance" />
                <XRef ID="45116002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">SPR deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SRD</ElementValue>
                <XRef Type="MIM" ID="612716" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10365" />
                <XRef ID="10365" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of sepiapterin reductase deficiency (SRD), which ranges from significant motor and cognitive deficits to only minimal findings, has not been completely elucidated. Clinical features in the majority of affected individuals include motor and speech delay, axial hypotonia, dystonia, weakness, and oculogyric crises; symptoms show diurnal fluctuation and sleep benefit. Other common features include parkinsonian signs (tremor, bradykinesia, masked facies, rigidity), limb hypertonia, hyperreflexia, intellectual disability, psychiatric and/or behavioral abnormalities, autonomic dysfunction, and sleep disturbances (hypersomnolence, difficulty initiating or maintaining sleep, and drowsiness). Most affected individuals have nonspecific features in infancy including developmental delays and axial hypotonia; other features develop over time.</Attribute>
                <XRef ID="NBK304122" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">26131547</ID>
                <ID Source="BookShelf">NBK304122</ID>
              </Citation>
              <XRef ID="70594" DB="Orphanet" />
              <XRef ID="C0268468" DB="MedGen" />
              <XRef ID="MONDO:0012994" DB="MONDO" />
              <XRef Type="MIM" ID="612716" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1454046" SubmissionDate="2017-12-18" DateLastUpdated="2022-12-11" DateCreated="2018-04-29">
        <ClinVarSubmissionID localKey="NM_003124.4:c.596del|MedGen:C0268468" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000746690" DateUpdated="2022-12-11" DateCreated="2018-04-29" Type="SCV" Version="2" SubmitterName="Genomic Research Center, Shahid Beheshti University of Medical Sciences" OrgID="504864" OrganizationCategory="laboratory" OrgAbbreviation="GRC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <GeographicOrigin>Iran</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003124.4:c.596del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268468" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>WES Dec 2017</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1454046" TraitType="Disease" MappingType="XRef" MappingValue="C0268468" MappingRef="MedGen">
        <MedGen CUI="C0268468" Name="Dopa-responsive dystonia due to sepiapterin reductase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

